SEC Company Response from Verax Research Services, Inc. (CIK 0001763987) — Mar 23, 2020
Verax Research Services, Inc. (CIK 0001763987)
Date: March 23, 2020 · CIK: 0001763987 · Accession: 0001477932-20-001449
AI Filing Summary & Sentiment
File numbers found in text: 024-11029
Letter
VIA EDGAR (Filed as Correspondence) Division of Corporation Finance Office of Beverages, Apparel and Mining Re: Verax Research Services, Inc. Correspondence to Amendment No. 3 to Its Offering Statement on Form 1-A Originally Filed June 28, 2019 File No. 024-11029
Dear Office of Beverages, Apparel and Mining:
On March 20, 2020, Verax Research Services, Inc. (the “Issuer”) filed a Request of Acceleration of its Form 1-A (File No. 024-11029) pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, to May 1, 2020, or as soon as practicable thereafter. Per the staff’s request late Friday, Registrant hereby withdraws such Request for Acceleration at this time.
Best Regards,
VERAX RESEARCH SERVICES, INC.
Show Raw Text
CORRESP
1
filename1.htm
verax_corresp.htm
March 23, 2020
VIA EDGAR (Filed as Correspondence)
Division of Corporation Finance
Attn.: Staff Counsel Ronald Alper, Esq. and Brigette Lippman, Esq.
Office of Beverages, Apparel and Mining
U.S. Securities and Exchange Commission
Washington, D. C. 20549
Re: Verax Research Services, Inc.
Correspondence to Amendment No. 3 to Its
Offering Statement on Form 1-A Originally Filed June 28, 2019
File No. 024-11029
Dear Office of Beverages, Apparel and Mining:
On March 20, 2020, Verax Research Services, Inc. (the “Issuer”) filed a Request of Acceleration of its Form 1-A (File No. 024-11029) pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, to May 1, 2020, or as soon as practicable thereafter. Per the staff’s request late Friday, Registrant hereby withdraws such Request for Acceleration at this time.
Best Regards,
VERAX RESEARCH SERVICES, INC.
/s/ Garrett Lindemann
Chief Executive Officer
cc: John Dolkart, Jr., Esq.
J. Randall Hoggle, Verax Chair
Vlad Uchenik, Dalmore Group
Etan Butler, Dalmore Group
VERAX RESEARCH AND TESTING CENTER @ HOPKINS -
JOHNS HOPKINS UNIVERSITY; MCC-ACADEMIC AND RESEARCH BUILDING 9601
MEDICAL CENTER DRIVE, ROCKVILLE, MARYLAND 20850
Office: (888) 214-2584 www.veraxresearch.com Fax: (240) 465-0519